Ratan Capital Management LP Adaptive Biotechnologies Corp Transaction History

Ratan Capital Management LP

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2020 Aug 14, 2020	SELL	$24.95 - $48.38 $1.04 Million - $2.01 Million	-41,550 Closed	0 $0
Q1 2020 May 15, 2020	SELL	$16.96 - $34.16 $337,504 - $679,783	-19,900 Reduced 32.38%	41,550 $1.15 Million
Q4 2019 Feb 14, 2020	BUY	$24.56 - $32.8 $495,571 - $661,838	20,178 Added 48.89%	61,450 $1.84 Million
Q3 2019 Nov 14, 2019	SELL	$30.31 - $53.51 $1.63 Million - $2.87 Million	-53,728 Reduced 56.56%	41,272 $1.28 Million
Q2 2019 Aug 14, 2019	BUY	$40.3 - $48.3 $3.83 Million - $4.59 Million	95,000 New	95,000 $4.59 Million

202

146M

68.8K

42.5K

Ticker ADPT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 142,872,992
Market Cap $853M
Description
Adaptive Biotechnologies Corporation, a commercial-stage company, develops an immune medicine platform for the diagnosis and treatment of various diseases. The company offers immunoSEQ, a platform and core immunosequencing product that is used to answer translational research questions, as well as to discover new prognostic and diagnostic signal...

Get notified when there are updates to the investment portfolio of Ratan Capital Management LP, based on Form 13F filings with the SEC.

Stay updated on Ratan Capital Management LP with notifications on news.